Truist Securities Initiates Coverage On ANI Pharmaceuticals with Buy Rating, Announces Price Target of $70
Truist Securities analyst Gregory Fraser initiates coverage on ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy rating and announces Price Target of $70.
64 Biggest Movers From Yesterday
Gainers
ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the company filed a mixed shelf offering on Friday after the close.
ANI Pharma’s Purified Cortrophin Gel Scores FDA Approval; Q3 Earnings Beat Estimates
ANI Pharmaceuticals Inc (NASDAQ:ANIP) has reported Q3 sales of $52.1 million, down 1.7% Y/Y, better than the consensus of $49.70…
Mid-Afternoon Market Update: loanDepot Surges After Q3 Results; Mirati Therapeutics Shares Slide
Toward the end of trading Monday, the Dow traded up 0.12% to 35,863.70 while the NASDAQ rose 0.18% to 15,525.52. The S&P, however, fell 0.10% to 4,600.81.
Mid-Day Market Update: Dow Rises 50 Points; ANI Pharmaceuticals Shares Jump
Midway through trading Monday, the Dow traded up 0.14% to 35,871.27 while the NASDAQ rose 0.23% to 15,534.49. The S&P also fell, dropping 0.03% to 4,603.98.
40 Stocks Moving In Monday’s Mid-Day Session
Gainers
ABVC BioPharma, Inc. (NASDAQ: ABVC) shares jumped 250% to $8.91 on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the company filed a mixed shelf offering on Friday after the close.
ANI Pharmaceuticals’s Return On Capital Employed Overview
According to Benzinga Pro data, during Q3, ANI Pharmaceuticals (NASDAQ:ANIP) posted sales of $52.06 million. Earnings were up 77.1%, but ANI Pharmaceuticals still reported an overall loss of $3.56 million.
Mid-Morning Market Update: Markets Mixed; PG&E Earnings Miss views
Following the market opening Monday, the Dow traded up 0.08% to 35,846.72 while the NASDAQ rose 0.18% to 15,527.04. The S&P also fell, dropping 0.07% to 4,602.32.
